Global Porokeratosis Treatment Market Overview
According to SPER Market Research, the Global Porokeratosis Treatment Market is estimated to reach USD 3.95 billion by 2032 with a CAGR of 6.89%
.
A cornoid lamella, a thin column of tightly packed, parakeratotic cells extending through the stratum corneum with a thin or non-existent granular layer, is a specific disease of keratinization known as porokeratosis. Because of abnormal keratinocyte clonal growth, porokeratosis is a rare skin disorder that, in the worst situation, can develop into skin cancer. The illness is associated with immunosuppression, UV radiation, systemic, viral, and neoplastic problems. The market for global porokeratosis therapy will grow for a variety of reasons, such as rising laser therapy demand, an increase in kidney transplant cases, better reimbursement laws in developed countries, rising research expenses, and rising competition among market traders. The porokeratosis treatment market is rising because to the growing awareness of the condition and the demand for better skin. If more worldwide treatment ideas are communicated, consumers are more likely to adopt porokeratosis therapy products and procedures. Numerous customers have been drawn in by government assistance and the adoption of improved reimbursement procedures in industrialized nations.
Impact of COVID-19 on the Global Porokeratosis Treatment Market
The COVID-19 pandemic has affected the world market. Significant commercial interruptions are being experienced by medical device manufacturers, suppliers, and healthcare organizations who offer cosmetic operations. This has a significant impact on product demand and production. Deliveries of commodities are now restricted by the ever-increasing number of virus-infected patients around the world. Additionally, clinics are usually inaccessible since cosmetic therapy is seen as non-essential during the pandemic. The impact on the market is further increased by the product's unavailability as a result of travel restrictions. Therapy and treatment are being disrupted as a result, and the COVID-19 Porokeratosis treatment market valuation has increased more slowly than anticipated in recent years.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2032 |
| Base year considered | 2021 |
| Forecast period | 2022-2032 |
| Segments covered | By Type, By Diagnosis and Treatment, By End User
|
| Regions covered | Asia-Pacific, Europe, Middle East and Africa, North America, Latin America
|
| Companies Covered | Allergan, Alma Lasers, Angiodynamics, Inc., Beiersdorf AG, Biogen, Biolase Inc., BIONESS, INC., Coherent, Inc., COTY INC., Cutera, Danaher Corporation, Hoffmann-la Roche Ltd, HOLOGIC INC., PFIZER
|
Target Audience-
- Academic Institutes and Universities
- Government Research Institutes
- Medical Devices Companies
- Pharmaceutical Companies
- Research and Development (R&D) Companies
Global Porokeratosis Treatment Market Segmentation:
1. By Type:
- Disseminated Actinic Porokeratosis
- Linear Porokeratosis
- Porokeratosis Eccrine Ostial and Dermal Duct Nevus
- Porokeratosis of Mantoux
- Punctate Porokeratosis
2. By Diagnosis and Treatment:
- Medications
- Photodynamic Therapy
- Cryotherapy
- Lasers
3. By End User:
- Diagnostic Centers
- Drug Stores
- Hospitals and Clinics
- Research and Academia Institutes
4. By Region:
- Asia-Pacific
- Europe
- Middle East and Africa
- North America
- Latin America
Key Topics Covered in the Report:
- Size of Global Porokeratosis Treatment Market (FY’2019-FY’2032)
- Overview of Global Porokeratosis Treatment Market
- Segmentation of Global Porokeratosis Treatment Market By Type (Disseminated Actinic Porokeratosis, Linear Porokeratosis, Porokeratosis Eccrine Ostial and Dermal Duct Nevus, Porokeratosis of Mantoux, Punctate Porokeratosis)
- Segmentation of Global Porokeratosis Treatment Market By Diagnosis and Treatment (Medications, Photodynamic Therapy, Cryotherapy, Lasers, Others)
- Segmentation of Global Porokeratosis Treatment Market By End User (Diagnostic Centers, Drug Stores, Hospitals and Clinics, Research and Academia Institutes, Others)
- Statistical Snap of Global Porokeratosis Treatment Market
- Global Porokeratosis Treatment Market Growth Analysis
- Problems and Challenges in Global Porokeratosis Treatment Market
- Global Porokeratosis Treatment Market Competitive Landscape
- Impact of COVID-19 and Demonetization on Global Porokeratosis Treatment Market
- Details on Recent Investment in Global Porokeratosis Treatment Market
- Competitive Analysis of Global Porokeratosis Treatment Market
- Major Players in the Global Porokeratosis Treatment Market
- SWOT Analysis of Global Porokeratosis Treatment Market
- Global Porokeratosis Treatment Market Future Outlook and Projections (FY’2019-FY’2032)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1 Research data source
2.1.1 Secondary data
2.1.2 Primary data
2.1.3 SPER’s internal database
2.1.4 Premium insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2. COVID-19 Impacts of the Global Porokeratosis Treatment Market
5. Market variables and outlook
5.1. SWOT analysis
5.1.1 Strengths
5.1.2 Weaknesses
5.1.3 Opportunities
5.1.4 Threats
5.2. PESTEL analysis
5.2.1 Political landscape
5.2.2 Economic landscape
5.2.3 Social landscape
5.2.4 Technological landscape
5.2.5 Environmental landscape
5.2.6 Legal landscape
5.3. PORTER’S five forces analysis
5.3.1 Bargaining power of suppliers
5.3.2 Bargaining power of Buyers
5.3.3 Threat of Substitute
5.3.4 Threat of new entrant
5.3.5 Competitive rivalry
5.4. Heat map analysis
6. Competitive Landscape
6.1 Global Porokeratosis Treatment Manufacturing Base Distribution, Sales Area, Product Type
6.2 Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Porokeratosis Treatment Market
7. Global Porokeratosis Treatment Market, By Type, 2019-2032 (USD Million)
7.1 Disseminated Actinic Porokeratosis
7.2 Linear Porokeratosis
7.3 Porokeratosis Eccrine Ostial and Dermal Duct Nevus
7.4 Porokeratosis of Mantoux
7.5 Punctate Porokeratosis
8. Global Porokeratosis Treatment Market, By Diagnosis and Treatment, 2019-2032 (USD Million)
8.1 Medications
8.2 Photodynamic Therapy
8.3 Cryotherapy
8.4 Lasers
8.5 Others
9. Global Porokeratosis Treatment Market, By End User ,2019-2032 (USD Million)
9.1 Diagnostic Centers
9.2 Drug Stores
9.3 Hospitals and Clinics
9.4 Research and Academia Institutes
9.5 Others
10. Global Porokeratosis Treatment Market, By Region, 2019-2032 (USD Million)
10.1 Global Porokeratosis Treatment Market and Market Share by Region (2019-2025)
10.2 Global Porokeratosis Treatment Market and Market Share by Region (2026-2032)
10.3 Asia-Pacific
10.3.1 Australia
10.3.2 China
10.3.3 India
10.3.4 Japan
10.3.5 South Korea
10.3.6 Rest of Asia-Pacific
10.4 Europe
10.4.1 France
10.4.2 Germany
10.4.3 Italy
10.4.4 Spain
10.4.5 United Kingdom
10.4.6 Rest of Europe
10.5 Middle East and Africa
10.5.1 Kingdom of Saudi Arabia
10.5.2 United Arab Emirates
10.5.3 Rest of Middle East & Africa
10.6 North America
10.6.1 Canada
10.6.2 Mexico
10.6.3 United States
10.7 Latin America
10.7.1 Argentina
10.7.2 Brazil
10.7.3 Rest of Latin America
11. Company Profiles
11.1 Allergan
11.1.1 Company details
11.1.2 Financial outlook
11.1.3 Product summary
11.1.4 Recent developments
11.2 Alma Lasers
11.2.1 Company details
11.2.2 Financial outlook
11.2.3 Product summary
11.2.4 Recent developments
11.3 Angiodynamics, Inc.
11.3.1 Company details
11.3.2 Financial outlook
11.3.3 Product summary
11.3.4 Recent developments
11.4 Beiersdorf AG
11.4.1 Company details
11.4.2 Financial outlook
11.4.3 Product summary
11.4.4 Recent developments
11.5 Biogen
11.5.1 Company details
11.5.2 Financial outlook
11.5.3 Product summary
11.5.4 Recent developments
11.6 Biolase Inc.
11.6.1 Company details
11.6.2 Financial outlook
11.6.3 Product summary
11.6.4 Recent developments
11.7 BIONESS, INC.
11.7.1 Company details
11.7.2 Financial outlook
11.7.3 Product summary
11.7.4 Recent developments
11.8 Coherent, Inc.
11.8.1 Company details
11.8.2 Financial outlook
11.8.3 Product summary
11.8.4 Recent developments
11.9 COTY INC.
11.9.1 Company details
11.9.2 Financial outlook
11.9.3 Product summary
11.9.4 Recent developments
11.10 Cutera
11.10.1 Company details
11.10.2 Financial outlook
11.10.3 Product summary
11.10.4 Recent developments
11.11 Danaher Corporation
11.11.1 Company details
11.11.2 Financial outlook
11.11.3 Product summary
11.11.4 Recent developments
11.12 Hoffmann-la Roche Ltd
11.12.1 Company details
11.12.2 Financial outlook
11.12.3 Product summary
11.12.4 Recent developments
11.13 HOLOGIC INC.
11.13.1 Company details
11.13.2 Financial outlook
11.13.3 Product summary
11.13.4 Recent developments
11.14 PFIZER
11.14.1 Company details
11.14.2 Financial outlook
11.14.3 Product summary
11.14.4 Recent developments
12. List of Abbreviations
13. Reference Links
14. Conclusion
15. Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
